Browsing byAuthorGillani, TB
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
2013-01-01 | Anti-proliferative actions of N0-desmethylsorafenib in human breast cancer cells | Cui, PH; Rawling, T; Gillani, TB; Bourget, K; Wang, XS; Zhou, F; Murray, M |
2018-03-01 | Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver | Murray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T |
2021-02-05 | Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite. | Nair, PC; Gillani, TB; Rawling, T; Murray, M |
2019-11-01 | Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib | Murray, M; Gillani, TB; Rawling, T; Nair, PC |
2019-03-01 | Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 | Ghassabian, S; Gillani, TB; Rawling, T; Crettol, S; Nair, PC; Murray, M |